Roquette

http://www.pharmtech.com/pt_w/formulations

	The issues surrounding the use of polysorbates within liquid biologic formulations are well known within the industry. What isn’t so well understood are the alternatives to this technology. This webcast will explore an exciting excipient, Kleptose® BioPharma, and its application within biologic formulations as a potential functional alternative to polysorbates. The webcast discussion will:

		Demonstrate the promise of this excipient in the development of biosimilars 

		Present data on how polysorbates can be functionally replaced in liquid dosage forms

		Provide data-driven insights into the mechanism of action for HP-beta-cyclodextrins in protein formulations

		Understand how cyclodextrins can be used in the formulation of biosimilars, especially those where the reference formulation contains polysorbates

		Understand the basic mechanism of action for cyclodextrins within protein formulations

		Learn how to tackle a new formulation challenge using cyclodextrins as an excipient tool

Peter Ferguson, Global Market Manager, BioPharma, Roquette BioPharma

	Peng Tao, Senior Scientist, R&D, Roquette BioPharma

Tuesday, Oct. 29, 2019 at 9am CDT | 10am EDT | 2pm GMT | 3pm CET

	On demand available after airing until Oct. 29, 2020

Webcasts

New research shows KLEPTOSE® BIOPHARMA as a potential functional alternative to surfactants within biologic formulations, learn more from Roquette’s experts Peter Ferguson and Pen Tao. 
Live: Tuesday, Oct. 29, 2019 at 9am CDT | 10am EDT | 2pm GMT | 3pm CET
On demand available after airing until Oct. 29, 2020 
Register free

Roquette

Articles